Colorectal cancer: Molecular genetic studies and their future clinical applications

Medical and Pediatric Oncology

Volumn 27, Issue SUPPL. 1, 1996, Pages 35-40

  Fearon, Eric R ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GENETICS; COLON CARCINOGENESIS; COLORECTAL CANCER; CONFERENCE PAPER; DNA DAMAGE; DNA REPAIR; FAMILIAL CANCER; GENE MUTATION; HUMAN; MOLECULAR GENETICS; ONCOGENE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; COLON TUMOR; DISEASE COURSE; FORECASTING; GENETICS; MOLECULAR BIOLOGY; MUTATION; RECTUM TUMOR; REVIEW;

COLONIC NEOPLASMS; DISEASE PROGRESSION; DNA DAMAGE; DNA REPAIR; FORECASTING; GENES, TUMOR SUPPRESSOR; HUMANS; MOLECULAR BIOLOGY; MUTATION; ONCOGENES; RECTAL NEOPLASMS;

EID: 0029690587     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(1996)27:1+<35::AID-MPO7>3.0.CO;2-O     Document Type: Conference Paper

References (57)

1. Bishop JM: Molecular themes in oncogenesis. Cell 64:235, 1991.
2. Hunter T. Cooperation between oncogenes. Cell 64:249, 1991.
3. Cantley LC, Auger KR, Carpenter C, et al: Oncogenes and signal transduction. Cell 64:281, 1991.
4. Weinberg R: Oncogenes and tumor suppressor genes. CA Cancer J Clin 44:160, 1994.
5. Marshall CJ: Tumor suppressor genes. Cell 64:213, 1991.
6. Knudson AG: Antioncogenes and human cancer. Proc Natl Acad Sci USA 90:10914, 1993.
7. Cleaver JE: It was a very good year for DNA repair. Cell 76:1, 1994.
8. Fishel R, Lescoe MK, Rao MRS, et al: The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancers. Cell 75:1027, 1993.
9. Leach FS, Nicolaides NC, Papdopoulos N, et al: Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75:1215, 1993.
10. Bronner CE, Baker SM, Morrison PT, et al: Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368:258, 1994.
11. Papadopoulos N, Nicolaides NC, Wei Y-F, et al: Mutation of a mutL homolog in hereditary colon cancer. Science 263:1625, 1994.
12. Liu B, Parsons RE, Hamilton SR, et al: hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res 54:4590, 1994.
13. Burt RW, Samowitz WS: The adenomatous polyp and the hereditary polyposis syndromes. Gastroenterol Clin North Am 17:657, 1988.
14. Herrera L, Kakati S, Gibas L, et al: Brief clinical report: Gardner syndrome in a man with interstitial deletion of 5q. Am J Med Genet 25:473, 1986.
15. Bodmer WF, Bailey C, Bodmer J, et al: Localization of the gene for familial polyposis on chromosome 5. Nature 328:614, 1987.
16. Leppert M, Dobbs M, Scambler P, et al: The gene for familial polyposis coli maps to the long arm of chromosome 5. Science 238:1411, 1987.
17. Groden J, Thlivers A, Samowitz W, et al: Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589, 1991.
18. Joslyn G, Carlson M, Thlivers A, et al: Identification of deletion mutations and three new genes at the familial polyposis locus. Cell 66:601, 1991.
19. Kinzler KW, Nilbert MC, Su L-K, et al: Identification of FAP locus genes from chromosome 5q21. Science 253:661, 1991.
20. Nishisho I, Nakamura Y, Miyoshi Y, et al: Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253:665, 1991.
21. Powell SM, Petersen GM, Krush AJ, et al: Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 329:1982, 1993.
22. Spirio L, Olschwang S, Groden J, et al: Alleles of the APC gene: an attenuated form of familial polyposis. Cell 75:951, 1993.
23. Powell WM, Zilz N, Beazer-Barclay Y, et al: APC mutations occur early during colorectal tumorigenesis. Nature 359:235, 1992.
24. Miyoshi Y, Nagase H, Ando H, et al: Somatic mutations of the APC gene in colorectal tumors: mutations cluster region in the APC gene. Hum Mol Genet 1:229, 1992.
25. Levy DB, Smith KJ, Beazer-Barclay Y, et al: Inactivation of both APC gene products with b-catenin. Science 253:665, 1993.
26. Rubinfeld B, Souza B, Albert I, et al: Association of the APC gene product with b-catenin. Science 253:665, 1993.
27. Su L-K, Vogelstein B, Kinzler KW. Association of the APC tumor suppressor protein with catenins. Science 262:1734, 1993.
28. Utsunomiya J, Lynch HT. "Hereditary Colorectal Cancer." New York: Springer-Verlag, 1990.
29. Lynch HT, Smyrk TC, Watson P, et al: Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 104:1535, 1993.
30. Nicolaides NC, Papadopoulous N, Lin B, et al: Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 371:75, 1994.
31. Aaltonen LA, Peltomaki P, Leach FS, et al: Clues to the pathogenesis of familial colorectal cancer. Science 260:812, 1993.
32. Thibodeau SN, Bren G, Schaid D: Microsatellite instability in cancer of the proximal colon. Science 260:816, 1993.
33. Vogelstein B, Fearon ER, Hamilton SR, et al: Genetic alterations during colorectal tumor development. N Engl J Med 319:525, 1988.
34. Miyaki M, Seki M, Okamoto M, et al: Genetic changes and histopathological types in colorectal tumors from patients with adenomatous polyposis. Cancer Res 50:7166, 1990.
35. Pretlow TP, Brasitus PA, Fulton NC, et al: K-ras mutations in putative preneoplastic lesions in human colon. J Natl Cancer Inst 85:2004, 1993.
36. Jen J, Powell SM, Papadopoulos N, et al: Molecular determinants of dysplasia in colorectal lesions. Cancer Res 54:5523, 1994.
37. Fearon ER. K-ras gene mutation as a pathogenetic and diagnostic marker in human cancer. J Natl Cancer Inst 85:1978, 1993.
38. Shirasawa S, Furuse M, Yokoyama N, et al: Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 260:85, 1993.
39. Fearon ER: Molecular abnormalities in colon and rectal cancer. In Mendelsohn J, Howley PM, Israel MA, Liotta LA (eds): "The Molecular Basis of Cancer." Philadelphia: WB Saunders Company, 1995, pp. 340-357.
40. Knudson AG Jr: Hereditary cancer, oncogenes and anti-oncogenes. Cancer Res 45:1437, 1985.
41. Vogelstein B, Fearon ER, Kern SE, et al: Allelotype of colorectal carcinomas. Science 244:207, 1989.
42. Baker SJ, Fearon ER, Nigro JM, et al: Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 24:207, 1989.
43. Baker SJ, Preisinger AC, Jessup JM, et al: p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 50:7717, 1990.
44. Friend SH: p53: a glimpse at the puppet behind the shadow play. Science 265:334, 1994.
45. Kastan MB, Zhan Q, El-Deiry WS, et al: A mammalian cell cycle check-point pathway utilizing p53 and GASS45 is detective in ataxia-telangiectasia. Cell 71:817, 1993.
46. El-Deiry WS, Tokino T, Velculescu VE, et al: WAF1, a potential mediator of p53 tumor suppression. Cell 75:817, 1993.
47. Harper JW, Adami GR, Wei N, et al: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805, 1993.
48. Lane DP: p53, guardian of the genome. Nature 358:15, 1992.
49. Fisher DE: Apoptosis in cancer therapy: crossing the threshold. Cell 78:539, 1994.
50. Ookawa K, Sakamoto M, Hirohashi S, Yoshida Y, Sugimura T, Terada M, Yokota J: Concordant p53 and DCC alterations and allelic losses on chromosomes 13q and 14q associated with liver metastases of colorectal carcinoma. Int J Cancer 53:382, 1993.
51. Jen J, Kim H, Piantodosi S, et al: Chromosome 18q loss and prognosis of colorectal cancer. N Engl J Med 331:213, 1994.
52. Fearon ER, Cho KR, Nigro JM, et al: Identification of a chromosome 18q gene which is altered in colorectal cancers. Science 247:49, 1990.
53. Cho KR, Oliner JD, Simons JW, et al: The DCC gene - structural analysis and mutations in colorectal carcinomas. Genomics 19:525, 1994.
54. Hefrick L, Cho KR, Fearon ER, et al: The DCC gene product in cellular differentiation and colorectal tumorigenesis. Genes Dev 8:1174, 1994.
55. Reale MA, Hu G, Zafar AI, et al: Expression and alternative splicing of the deleted in colorectal cancer (DCC) gene in normal and malignant tissues. Cancer Res 54:4493, 1994.
56. Sidransky D, Tokino T, Hamilton SR, et al: Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 256:102, 1992.
57. Gibbs JB, Oliff A, Kohl NE: Farnesyltransferase inhibitors: ras research yields a potential cancer therapeutic. Cell 77:175, 1994.